Prevalence of CYP2C9 polymorphisms in the south of Europe.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 306, doi. 10.1038/tpj.2009.16
- By:
- Publication type:
- Article
Works matching IS 1470269X AND DT 2009 AND VI 9 AND IP 5
Results: 8
1
2
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 347, doi. 10.1038/tpj.2009.19
- By:
- Publication type:
- Article
3
Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 341, doi. 10.1038/tpj.2009.20
- By:
- Publication type:
- Article
4
Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 319, doi. 10.1038/tpj.2009.21
- By:
- Publication type:
- Article
5
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 311, doi. 10.1038/tpj.2009.24
- By:
- Publication type:
- Article
6
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 333, doi. 10.1038/tpj.2009.27
- By:
- Publication type:
- Article
7
Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 291, doi. 10.1038/tpj.2009.29
- By:
- Publication type:
- Article
8
Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 5, p. 327, doi. 10.1038/tpj.2009.34
- By:
- Publication type:
- Article